New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Protein Therapeutics Market recovers from Great Recession in part due to growth in monoclonal antibodies market
FARMINGTON, Conn., May 9, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new reports in rapidly expanding Protein Therapy market:
Global Protein Therapeutics Market Forecast to 2015
Protein-based therapies have become one of the most effective clinical methods to treat wide spectrum of diseases, ranging from cancer to metabolic disorders. While worldwide healthcare spending has decline in the post- Great Recession economy, the protein therapeutics market has continued to grow at a steady rate. The protein therapeutics market still holds tremendous growth potential, and RNCOS E-Services estimates in their new Global Protein Therapeutics Market Forecast that the market will reach $143.4 billion by 2015.
This report expects that a range of new products, especially monoclonal antibodies in the advanced clinical phase, will enter the market to drive growth upward. In this context, the report gives a comprehensive analysis of the current and future patterns of revenue generation with respect to monoclonal antibodies and other segments.
A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/rnc235810-global-protein-therapeutics-market-forecast-2015.html
Cancer Monoclonal Antibody Partnering Agreements
Current Partnering, a division of Wildwood Ventures Limited, provides in their new report Cancer Monoclonal Antibody Partnering Agreements an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the world's leading healthcare companies.
The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
This new Cancer Monoclonal Antibody Partnering Agreements report provides comprehensive access to available deals and contract documents for over 1,000 cancer monoclonal antibody deals.
An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia, Global Information, Inc., 860-674-8796, USfirstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.Back to top